{"id":339,"date":"2023-07-11T14:56:00","date_gmt":"2023-07-11T06:56:00","guid":{"rendered":"https:\/\/metabiopharma.com\/?p=339"},"modified":"2024-03-20T15:20:05","modified_gmt":"2024-03-20T07:20:05","slug":"mo_wu_lian_he_chuang_shi_ren_cto_xian_yu_an_jin_bo_shi_rong_deng_2023_nian_u40_qing_nian_jing_ying","status":"publish","type":"post","link":"http:\/\/en.metabiopharma.com\/index.php\/2023\/07\/11\/mo_wu_lian_he_chuang_shi_ren_cto_xian_yu_an_jin_bo_shi_rong_deng_2023_nian_u40_qing_nian_jing_ying\/","title":{"rendered":"Dr. Anjin XianYu, Co-Founder &#038; CTO of \u00a0META Pharmaceuticals, was named to the U40 Young Elite 2023 list.\ufffc"},"content":{"rendered":"\n<p>Recently, E Drug Manager launched the selection process for the U40 Young Elite 2023. Dr. Anjin Xianyu, co-founder and CTO of Shenzhen Moyuan Biotechnology Co., Ltd (META Pharmaceuticals), was recognized as a young leader and outstanding entrepreneur in the field of biomedical research. He was honored to be included in the U40 Young Elite List.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" width=\"259\" height=\"1024\" src=\"https:\/\/metabiopharma.com\/wp-content\/uploads\/2023\/07\/image-2-259x1024.png\" alt=\"\" class=\"wp-image-340\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2023\/07\/image-2-259x1024.png 259w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2023\/07\/image-2-76x300.png 76w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2023\/07\/image-2.png 313w\" sizes=\"(max-width: 259px) 100vw, 259px\" \/><\/figure>\n\n\n\n<p>\u300aE\u836f\u7ecf\u7406\u4eba\u300b\u521b\u520a\u4e8e2008\u5e74\uff0c\u662f\u81f4\u529b\u4e8e\u628a\u533b\u836f\u7814\u53d1\u65b0\u4ea7\u54c1\u3001\u751f\u4ea7\u6d41\u901a\u3001\u4ea7\u4e1a\u76d1\u7ba1\u4e0e\u670d\u52a1\u673a\u6784\u3001\u8d44\u672c\u7b49\u8d44\u8bafFounded in 2008, E Pharmaceutical Manager is a financial magazine dedicated to disseminating information on pharmaceutical R&amp;D, new products, production, distribution, industrial regulations, and service organizations. It serves as a high-end media platform for the industry, promoting information symmetry and uncovering value. The U40 Young Elite 2023 represents the outstanding future leaders of the pharmaceutical industry across five fields: entrepreneurship, investment, research and development (R&amp;D), secretarial roles, and business development (BD). These young talents are selected by the magazine after rigorous rounds of verification and voting.<\/p>\n\n\n\n<p>E\u836f\u7ecf\u7406\u4eba\u8ba4\u4e3a\uff0cU40\u00b7\u9752\u5e74\u521b\u4e1a\u83c1\u82f1\u699c\u7684\u4e0a\u699c\u5609\u5bbe\u4e2d\u201c\u542b\u535a\u91cf\u201d\u6781\u9ad8\uff0c\u4e14AI\u836f\u7269\u7814\u53d1\u3001\u7ec6\u80de\u4e0e\u57fa\u56e0\u6cbb\u7597\u7b49\u524d\u6cbfE Drug Managers believe that the U40 Young Entrepreneurial Elite List features highly accomplished individuals. Notably, young entrepreneurs in cutting-edge areas such as AI drug research and development, cell therapy, and gene therapy are prominently represented.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full\"><img loading=\"lazy\" width=\"481\" height=\"492\" src=\"https:\/\/metabiopharma.com\/wp-content\/uploads\/2023\/07\/image-3.png\" alt=\"\" class=\"wp-image-341\" srcset=\"http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2023\/07\/image-3.png 481w, http:\/\/en.metabiopharma.com\/wp-content\/uploads\/2023\/07\/image-3-293x300.png 293w\" sizes=\"(max-width: 481px) 100vw, 481px\" \/><\/figure><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Recently, E Drug Manager launched the selection process [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[],"_links":{"self":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/339"}],"collection":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/comments?post=339"}],"version-history":[{"count":2,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/339\/revisions"}],"predecessor-version":[{"id":404,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/posts\/339\/revisions\/404"}],"wp:attachment":[{"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/media?parent=339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/categories?post=339"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/en.metabiopharma.com\/index.php\/wp-json\/wp\/v2\/tags?post=339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}